BridgeMD
Compares treatment options for Aging
Official title Evaluation of Efficacy of Anthelios Sunscreen on Face Versus Usual Routine on Signs of Aging
ClinicalTrials.gov ID: NCT06697288
What this study is testing
- What it's testing
- This experimental, randomized study aims at evaluating the preventative effect of a Sun Protection Factor (SPF) 50+ sunscreen (Anthelios UVMUNE 400 Fluid SPF 50+) with high Ultraviolet A (UVA) protection on clinical signs of skin aging.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 60. Healthy volunteers may be eligible.
You may be able to join if
- people with signs of photo aging (Global score of at least 14)
- All skin types
You likely can't join if
- Any history of significant dermatological/ophthalmological diseases or conditions or medical conditions known to alter skin appearance or physiologic...
- Pregnant or breastfeeding women
- Subject with known allergy to cosmetic products or to any ingredient of the sunscreen product
The study team makes the final eligibility decision.
Where it's taking place
- Rio de Janeiro, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rio de Janeiro, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.